Minerva Neurosciences (NERV) Prepaid Assets (2013 - 2026)
Minerva Neurosciences (NERV) reported Prepaid Assets of $941883.0 for Q1 2026, up 76.12% on a YoY basis from $534798.0 in Q1 2025, and up 35.0% quarter-over-quarter from $697676.0 in Q4 2025.
Minerva Neurosciences (NERV) Prepaid Assets (2013 - 2026) Analysis & Trends
Minerva Neurosciences has reported Prepaid Assets for 14 years, with the latest figure at $941883.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 76.12% year-over-year to $941883.0; the trailing twelve-month figure through Mar 2026 stood at $941883.0 (up 76.12% YoY), and the FY2025 full-year result was $697676.0, down 13.54% from the prior year.
- Prepaid Assets for Q1 2026 stood at $941883.0, up from $697676.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.4 million in Q3 2022, with the low at $184821.0 in Q2 2022.
- Historically, Prepaid Assets has averaged $733855.5 across 5 years, with a median of $697676.0 in 2025.
- Annual changes were most pronounced in 2022 — Prepaid Assets sank 79.7% — and 2023, when it jumped 78.09%.
- Minerva Neurosciences' Prepaid Assets stood at $848117.0 in 2022, then increased by 16.71% to $989865.0 in 2023, then dropped by 18.48% to $806895.0 in 2024, then retreated by 13.54% to $697676.0 in 2025, then jumped by 35.0% to $941883.0 in 2026.
- The last three Prepaid Assets figures came in at $941883.0 (Q1 2026), $697676.0 (Q4 2025), and $633533.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Minerva Neurosciences | 197.55 Mn | 197.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 941,883.00 |
| Dec 31, 2025 | 697,676.00 |
| Sep 30, 2025 | 633,533.00 |
| Jun 30, 2025 | 199,615.00 |
| Mar 31, 2025 | 534,798.00 |
| Dec 31, 2024 | 806,895.00 |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 428,018.00 |
| Mar 31, 2024 | 702,546.00 |
| Dec 31, 2023 | 989,865.00 |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 329,153.00 |
| Mar 31, 2023 | 596,045.00 |
| Dec 31, 2022 | 848,117.00 |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 184,821.00 |
| Mar 31, 2022 | 650,481.00 |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 910,577.00 |